doi:10.3969/j.issn.1004-583X.2022.04.015

Abstract

CLC Number:

R743

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.04.015

https://huicui.hebmu.edu.cn/EN/Y2022/V37/I4/364

References 44

[1]	Gorelick PB, Scuteri A, Black SE. et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association/american stroke association[J]. Stroke, 2011, 42(9):2672-2713. doi: 10.1161/STR.0b013e3182299496 pmid: 21778438
[2]	Toyama K, Spin JK, Mogi M. et al. Therapeutic perspective on vascular cognitive impairment[J]. Pharmacol Res, 2019, 146:104266. doi: 10.1016/j.phrs.2019.104266 URL
[3]	Kang YC, Zhang L, Su Y. et al. MicroRNA-26b regulates the microglial inflammatory response in hypoxia/Ischemia and affects the development of vascular cognitive impairment[J]. Front Cell Neurosci, 2018, 12:154.
[4]	Toyama K, Spin JM, Tsao PS. Role of microRNAs on blood brain barrier dysfunction in vascular cognitive impairment[J]. Curr Drug Deliv, 2017, 14(6) : 744-757.
[5]	Marchegiani F, Matacchione G, Ramini D. et al. Diagnostic performance of new and classic CSF biomarkers in age-related dementias[J]. Aging (Albany NY), 2019, 11(8):2420-2429.
[6]	Toyama K, Spin JM, Deng AC. et al. MicroRNA-mediated therapy modulating blood-brain barrier disruption improves vascular cognitive impairment[J]. Arterioscler Thromb Vasc Biol, 2018, 38(6):1392-1406. doi: 10.1161/ATVBAHA.118.310822 URL
[7]	Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells[J]. J Leukoc Biol, 2010, 87(5):779-789. doi: 10.1189/jlb.1109766 URL
[8]	Shangguan Y, Han J, Su H. GAS5 knockdown ameliorates apoptosis and inflammatory response by modulating miR-26b-5p/Smad 1axis in cerebral ischaemia/reperfusion injury[J]. Behav Brain Res, 2020, 379:112370. doi: 10.1016/j.bbr.2019.112370 pmid: 31751592
[9]	Chen L, Dong R, Lu Y. et al. MicroRNA-146a protects against cognitive decline induced by surgical trauma by suppressing hippocampal neuroinflammation in mice[J]. Brain Behav Immun, 2019, 78:188-201. doi: S0889-1591(18)30518-X pmid: 30685530
[10]	Yuan M, Bi X. Therapeutic and diagnostic potential of microRNAs in vascular cognitive impairment[J]. J Mol Neurosci, 2020, 70(10):1619-1628. doi: 10.1007/s12031-020-01597-6 pmid: 32476095
[11]	Wang D, Duan H, Feng J. et al. Soluble CD146, a cerebrospinal fluid marker for neuroinflammation, promotes blood-brain barrier dysfunction[J]. Theranostics, 2020, 10(1):231-246. doi: 10.7150/thno.37142 URL
[12]	李文倩, 吕鹤群, 彭拥军, 等. 缺血性脑卒中后血脑屏障损伤机制研究现状[J]. 中国临床药理学杂志, 2020, 36(21) :3533-3537.
[13]	Seo S, Kim H, Sung JH. et al. Microphysiological systems for recapitulating physiology and function of blood-brain barrier[J]. Biomaterials, 2020, 232:119732. doi: 10.1016/j.biomaterials.2019.119732 URL
[14]	Fang Z, He QW, Li Q. et al. MicroRNA-150 regulates blood-brain barrier permeability via Tie-2 after permanent middle cerebral artery occlusion in rats[J]. FASEB J, 2016, 30(6):2097-2107. doi: 10.1096/fj.201500126 pmid: 26887441
[15]	Ma F, Sun P, Zhang X. et al. Endothelium-targeted deletion of the miR-15a/16-1 cluster ameliorates blood-brain barrier dysfunction in ischemic stroke[J]. Sci Signal, 2020, 13(626):eaay5686.
[16]	Burek M, König A, Lang M. et al. Hypoxia-Induced microRNA-212/132 alter blood-brain barrier integrity through inhibition of tight junction-associated proteins in human and mouse brain microvascular endothelial cells[J]. Transl Stroke Res, 2019, 10(6):672-683. doi: 10.1007/s12975-018-0683-2 URL
[17]	Reijerkerk A, Lopez-Ramirez MA, van Het Hof B. et al. MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: Implications for multiple sclerosis[J]. J Neurosci, 2013, 33(16):6857-6863. doi: 10.1523/JNEUROSCI.3965-12.2013 pmid: 23595744
[18]	Ma Q, Dasgupta C, Li Y. et al. MicroRNA-210 suppresses junction proteins and disrupts blood-brain barrier integrity in neonatal rat hypoxic-ischemic brain injury[J]. Int J Mol Sci, 2017, 18(7):1356. doi: 10.3390/ijms18071356 URL
[19]	Prabhakar P, Chandra SR, Christopher R. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease[J]. Age Ageing, 2017, 46(5):861-864. doi: 10.1093/ageing/afx090 URL
[20]	Michely J, Kraft S, Müller U. MiR-12 and miR-124 contribute to defined early phases of long-lasting and transient memory[J]. Sci Rep, 2017, 7(1):7910. doi: 10.1038/s41598-017-08486-w pmid: 28801686
[21]	彭飞飞, 陶晓晓, 章熠, 等. 急性脑梗死患者外周血微RNA的表达及其与炎性因子的关系[J]. 重庆医学, 2020, 49(22):3772-3777.
[22]	Hu XL, Wang XX, Zhu YM. et al. MicroRNA-132 regulates total protein of Nav1.1 and Nav1.2 in the hippocampus and cortex of rat with chronic cerebral hypoperfusion[J]. Behav Brain Res, 2019, 366:118-125. doi: 10.1016/j.bbr.2019.03.026 URL
[23]	Ren Z, Yu J, Wu Z. et al. MicroRNA-210-5p contributes to cognitive impairment in early vascular dementia rat model through targeting snap25[J]. Front Mol Neurosci, 2018, 11:388. doi: 10.3389/fnmol.2018.00388 URL
[24]	Yao ZH, Yao XL, Zhang Y. et al. MiR-132 down-regulates methyl CpG binding protein 2 (MeCP2) during cognitive dysfunction following chronic cerebral hypoperfusion[J]. Curr Neurovasc Res, 2017, 14(4):385-396. doi: 10.2174/1567202614666171101115308 URL
[25]	Mo Y, Sun YY, Liu KY. Autophagy and inflammation in ischemic stroke[J]. Neural Regen Res, 2020, 15(8):1388-1396. doi: 10.4103/1673-5374.274331 URL
[26]	黄可群, 刘琳, 崔巍, 等. MicroRNA调控认知功能的研究进展[J]. 中华脑科疾病与康复杂志, 2020, 10(1):53-56.
[27]	Dong H, Li J, Huang L. et al. Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer's disease[J]. Dis Markers, 2015, 2015:625659.
[28]	Yu P, Venkat P, Chopp M. et al. Role of microRNA-126 in vascular cognitive impairment in mice[J]. J Cereb Blood Flow Metab, 2019, 39(12):2497-2511. doi: 10.1177/0271678X18800593 URL
[29]	Bijkerk R, Kallenberg MH, Zijlstra LE. et al. Circulating angiopoietin-2 and angiogenic microRNAs associate with cerebral small vessel disease and cognitive decline in older patients reaching end-stage renal disease[J]. Nephrol Dial Transplant, 2022, 37(3):498-506. doi: 10.1093/ndt/gfaa370 URL
[30]	Jakaria M, Haque ME, Cho DY. et al. Molecular insights into NR4A2(Nurr1): An emerging target for neuroprotective therapy against neuroinflammation and neuronal cell death[J]. Mol Neurobiol, 2019, 56(8):5799-5814. doi: 10.1007/s12035-019-1487-4 pmid: 30684217
[31]	Prendecki M, Florczak-Wyspianska J, Kowalska M. et al. APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer's disease[J]. Folia Neuropathol, 2019, 57(2):106-116. doi: 36523 pmid: 31556571
[32]	Gao ZF, Ji XL, Gu J. et al. MicroRNA-107 protects against inflammation and endoplasmic reticulum stress of vascular endothelial cells via KRT1-dependent Notch signaling pathway in a mouse model of coronary atherosclerosis[J]. J Cell Physiol, 2019, 234(7):12029-12041. doi: 10.1002/jcp.27864 URL
[33]	Lu Y, Xu X, Dong R. et al. MicroRNA-181b-5p attenuates early postoperative cognitive dysfunction by suppressing hippocampal neuroinflammation in mice[J]. Cytokine, 2019, 120:41-53. doi: 10.1016/j.cyto.2019.04.005 URL
[34]	Zhao Y, Gan Y, Xu G. et al. Eexosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation[J]. Life Sci, 2020, 260:118403. doi: 10.1016/j.lfs.2020.118403 URL
[35]	Ouyang Y, Li D, Wang H. et al. MiR-21-5p/dual-specificity phosphatase 8 signalling mediates the anti-inflammatory effect of haem oxygenase-1 in aged intracerebral haemorrhage rats[J]. Aging Cell, 2019, 18(6):e13022.
[36]	Lossi L, Castagna C, Merighi A. Caspase-3 mediated cell death in the normal development of the mammalian cerebellum[J]. Int J Mol Sci, 2018, 19(12):3999. doi: 10.3390/ijms19123999 URL
[37]	Catanesi M, d'Angelo M, Tupone MG. et al. MicroRNAs dysregulation and mitochondrial dysfunction in neurodegenerative diseases[J]. Int J Mol Sci, 2020, 21(17):5986. doi: 10.3390/ijms21175986 URL
[38]	Wang Y, Gu T, Shi E. et al. Inhibition of microRNA-29c protects the brain in a rat model of prolonged hypothermic circulatory arrest[J]. J Thorac Cardiovasc Surg, 2015, 150(3):675-84.e1. doi: 10.1016/j.jtcvs.2015.04.062 URL
[39]	Liu P, Liu P, Wang Z. et al. Inhibition of microRNA-96 ameliorates cognitive impairment and inactivation autophagy following chronic cerebral hypoperfusion in the rat[J]. Cell Physiol Biochem, 2018, 49(1):78-86. doi: 10.1159/000492844 URL
[40]	Che H, Yan Y, Kang XH. et al. MicroRNA-27a promotes inefficient lysosomal clearance in the hippocampi of rats following chronic brain hypoperfusion[J]. Mol Neurobiol, 2017, 54(4):2595-2610. doi: 10.1007/s12035-016-9856-8 URL
[41]	Zhang Y, Liu C, Wang J. et al. MiR-299-5p regulates apoptosis through autophagy in neurons and ameliorates cognitive capacity in APPswe/PS1dE9 mice[J]. Sci Rep, 2016, 6:24566. doi: 10.1038/srep24566 URL
[42]	Hwang JY, Kaneko N, Noh KM. et al. The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die[J]. J Mol Biol, 2014, 426(20):3454-3466. doi: 10.1016/j.jmb.2014.07.032 URL
[43]	Hansen KF, Karelina K, Sakamoto K. et al. MiRNA-132: A dynamic regulator of cognitive capacity[J]. Brain Struct Funct, 2013, 218(3): 817-831. doi: 10.1007/s00429-012-0431-4 URL
[44]	Danka Mohammed CP, Park JS, Nam HG. et al. MicroRNAs in brain aging[J]. Mech Ageing Dev, 2017, 168:3-9. doi: S0047-6374(16)30237-8 pmid: 28119001

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 44

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Liang Bingsong, Li Yuying, Zhang Qiping, Chen Yingdao, Li jian. Analysis of factors affecting clinical efficacy of Tirofiban in treating branch atheromatous disease [J]. Clinical Focus, 2023, 38(12): 1091-1094.
[2]	Luo Weigang, Xu Yuzhu, Zhang Lingyan, Wu Xiangyun, Bu Wei, Ren Huiling. Predictive value of the platelet function PFA-200 P2Y on the secondary prevention of acute ischemic stroke with clopidogrel [J]. Clinical Focus, 2023, 38(11): 979-983.
[3]	Zhu Fangfang, Wei Xuezhi, Feng Min. Effect of total magnetic resonance imaging burden on the cognitive function in patients with cerebral small vessel diseases [J]. Clinical Focus, 2023, 38(11): 984-990.
[4]	Yu Yifu, Yuan Chunhua. Research on the effects of diaphragm relaxation technique combined with resistance breathing training on motor ability of stroke survivors [J]. Clinical Focus, 2023, 38(11): 1002-1007.
[5]	. [J]. Clinical Focus, 2023, 38(11): 1034-1037.
[6]	Xu Wendeng, Shen Yi, Zhang Xiaofeng. Correlation between nonspecific ST-T abnormalities in electrocardiogram and recurrence of acute ischemic stroke [J]. Clinical Focus, 2023, 38(10): 883-886.
[7]	Li Zhiyong, Li Xing. Clinical value of multimodal ultrasound in screening middle cerebral artery stenosis in hypertensive patients [J]. Clinical Focus, 2023, 38(7): 613-617.
[8]	Xin Yanhong, Lang Guiyan, Chen Ziwei, Wang Dongyu. Value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting cognitive impairment in patients with acute mild ischemic stroke [J]. Clinical Focus, 2023, 38(6): 504-509.
[9]	Xin Zaie. Subarachnoid hemorrhage misdiagnosed as menigitis: A case report and literature review [J]. Clinical Focus, 2023, 38(5): 448-450.
[10]	He Xiangyu, Pan Yan, Zhang Xiaolin. Correlation between serum lipoprotein-associated phospholipase A2 level and the severity and prognosis of acute ischemic stroke [J]. Clinical Focus, 2023, 38(4): 315-318.
[11]	Jia Yangjuan, Han Ning, Guo Hui, Li Yanpeng, Li Cancan, Li Jianguo. Value of Mini Mental State Examination and Montreal Cognitive Assessment in screening mild vascular cognitive impairment at post-stroke [J]. Clinical Focus, 2023, 38(3): 221-226.
[12]	Yao Meifen, Ding Gangyu, Xu Jianhua, Wang Guojiang. Efficacy and safety of recombinant tissue plasminogen activator in patients with acute mild ischemic stroke [J]. Clinical Focus, 2023, 38(3): 227-231.
[13]	Zhao Yue, Zhang Shaohua, Zhao Zhenbiao, Yan Yanning, Sun Zengxin, Wang Xiaohan, Lyu Peiyuan, Yin Yu. Evaluation and cognitive training of eye tracking technology in right-sided unilateral neglect patients: A case report and literature review [J]. Clinical Focus, 2023, 38(3): 268-272.
[14]	Ma Hongli, Lu Hao, Wang Dan, Jiao Haixing, Li Yike, Li Siyu, Lu Jing. Meta-analysis of disability risk factors in stroke patients [J]. Clinical Focus, 2023, 38(2): 111-116.
[15]	Dong Siyu, Sun Mei, Tian Yufei, Cheng Hong, He Chuan. Delayed encephalitis after embolization of brain arteriovenous malformations: A case report and literature review [J]. Clinical Focus, 2023, 38(2): 170-174.